Your browser doesn't support javascript.
loading
Honing-in antigen-specific cells during antibody discovery: a user-friendly process to mine a deeper repertoire.
Mahendra, Ankit; Haque, Aftabul; Prabakaran, Ponraj; Mackness, Brian C; Fuller, Thomas P; Liu, Xiaohua; Kathuria, Sagar V; Wang, Yui-Hsi; Amatya, Nilesh; Yu, Xiaocong; Hopke, Joern; Hoffmann, Dietmar; Bric-Furlong, Eva; Zhang, Ningning; Cho, Hyun-Suk; Zhang, Ruijun; Sancho, Jose; Saleh, Jacqueline; Rao, Sambasiva P; Wendt, Maria; Chowdhury, Partha S.
Afiliação
  • Mahendra A; Large Molecule Research, Sanofi, 49 New York Avenue, Framingham, MA, USA. ankit.mahendra@sanofi.com.
  • Haque A; Large Molecule Research, Sanofi, 49 New York Avenue, Framingham, MA, USA.
  • Prabakaran P; Large Molecule Research, Sanofi, 49 New York Avenue, Framingham, MA, USA.
  • Mackness BC; Large Molecule Research, Sanofi, 49 New York Avenue, Framingham, MA, USA.
  • Fuller TP; Large Molecule Research, Sanofi, 49 New York Avenue, Framingham, MA, USA.
  • Liu X; Large Molecule Research, Sanofi, 49 New York Avenue, Framingham, MA, USA.
  • Kathuria SV; Large Molecule Research, Sanofi, 49 New York Avenue, Framingham, MA, USA.
  • Wang YH; Immunology & Inflammation Research, Genomics Center, Sanofi, 270 Albany Street, Cambridge, MA, USA.
  • Amatya N; Immunology & Inflammation Research, Genomics Center, Sanofi, 270 Albany Street, Cambridge, MA, USA.
  • Yu X; Large Molecule Research, Sanofi, 49 New York Avenue, Framingham, MA, USA.
  • Hopke J; Molecular Expression and Screening Technologies, Sanofi, 270 Albany Street, Cambridge, MA, USA.
  • Hoffmann D; Molecular Expression and Screening Technologies, Sanofi, 270 Albany Street, Cambridge, MA, USA.
  • Bric-Furlong E; Molecular Expression and Screening Technologies, Sanofi, 270 Albany Street, Cambridge, MA, USA.
  • Zhang N; Large Molecule Research, Sanofi, 49 New York Avenue, Framingham, MA, USA.
  • Cho HS; Large Molecule Research, Sanofi, 49 New York Avenue, Framingham, MA, USA.
  • Zhang R; Large Molecule Research, Sanofi, 49 New York Avenue, Framingham, MA, USA.
  • Sancho J; Neuroinflammation, Sanofi Genzyme, 49 New York Avenue, Framingham, MA, USA.
  • Saleh J; Neuroinflammation, Sanofi Genzyme, 49 New York Avenue, Framingham, MA, USA.
  • Rao SP; Large Molecule Research, Sanofi, 49 New York Avenue, Framingham, MA, USA.
  • Wendt M; Large Molecule Research, Sanofi, 49 New York Avenue, Framingham, MA, USA.
  • Chowdhury PS; Large Molecule Research, Sanofi, 49 New York Avenue, Framingham, MA, USA. pchowd15@its.jnj.com.
Commun Biol ; 5(1): 1157, 2022 10 30.
Article em En | MEDLINE | ID: mdl-36310321
ABSTRACT
Immunization based antibody discovery is plagued by the paucity of antigen-specific B cells. Identifying these cells is akin to finding needle in a haystack. Current and emerging technologies while effective, are limited in terms of capturing the antigen-specific repertoire. We report on the bulk purification of antigen-specific B-cells and the benefits it offers to various antibody discovery platforms. Using five different antigens, we show hit rates of 51-88%, compared to about 5% with conventional methods. We also show that this purification is highly efficient with loss of only about 2% antigen specific cells. Furthermore, we compared clones in which cognate chains are preserved with those from display libraries in which chains either from total B cells (TBC) or antigen-specific B cells (AgSC) underwent combinatorial pairing. We found that cognate chain paired clones and combinatorial clones from AgSC library had higher frequency of functional clones and showed greater diversity in sequence and paratope compared to clones from the TBC library. This antigen-specific B-cell selection technique exemplifies a process improvement with reduced cycle time and cost, by removing undesired clones prior to screening and increasing the chance of capturing desirable and rare functional clones in the repertoire.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunização / Anticorpos Tipo de estudo: Prognostic_studies Idioma: En Revista: Commun Biol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunização / Anticorpos Tipo de estudo: Prognostic_studies Idioma: En Revista: Commun Biol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos